Menlo Therapeutics

Developer of serlopitant drugs for the treatment of severe, chronic pruritus

placeMenlo Park, California, United States calendar_todayFounded 2011 groups40 employees language menlotherapeutics.com

Registered entities

Investor mix

12 investors on record; lead investors include VenBio.

Investor typeCountShare
Venture capital867%
Private equity217%
Other / undisclosed217%
Coming soon